|Signatures of mutational processes in human cancer|
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
|Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies|
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
The American Journal of Human Genetics 72 (5), 1117-1130, 2003
|Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families|
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
The American Journal of Human Genetics 62 (3), 676-689, 1998
|Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL|
J Zha, H Harada, E Yang, J Jockel, SJ Korsmeyer
Cell 87 (4), 619-628, 1996
|Landscape of somatic mutations in 560 breast cancer whole-genome sequences|
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
|The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds|
SV Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, ...
Nature genetics 12 (3), 333-337, 1996
|A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes|
S Thorlacius, G Olafsdottir, L Tryggvadottir, S Neuhausen, JG Jonasson, ...
Nature genetics 13 (1), 117-119, 1996
|The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.|
M Olivier, A Langer, P Carrieri, J Bergh, S Klaar, J Eyfjord, C Theillet, ...
Clinical cancer research 12 (4), 1157-1167, 2006
|The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions|
AC Antoniou, AP Cunningham, J Peto, DG Evans, F Lalloo, SA Narod, ...
British journal of cancer 98 (8), 1457-1466, 2008
|HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures|
H Davies, D Glodzik, S Morganella, LR Yates, J Staaf, X Zou, ...
Nature medicine 23 (4), 517, 2017
|Population-based study of risk of breast cancer in carriers of BRCA2 mutation|
S Thorlacius, JP Struewing, P Hartage, GH Olafsdottir, H Sigvaldason, ...
The Lancet 352 (9137), 1337-1339, 1998
|Study of a single BRCA2 mutation with high carrier frequency in a small population.|
S Thorlacius, S Sigurdsson, H Bjarnadottir, G Olafsdottir, JG Jonasson, ...
American journal of human genetics 60 (5), 1079, 1997
|Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.|
IBC Group, IBC Group
Science 345 (345(6196):1251343), 2014
|Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer|
V Birgisdottir, OA Stefansson, SK Bodvarsdottir, H Hilmarsdottir, ...
Breast cancer research 8 (4), 1-10, 2006
|Prostate cancer progression and survival in BRCA2 mutation carriers|
L Tryggvadóttir, L Vidarsdóttir, T Thorgeirsson, JG Jonasson, ...
Journal of the National Cancer Institute 99 (12), 929-935, 2007
|Screening for germ line TP53 mutations in breast cancer patients|
AL Børresen, TI Andersen, J Garber, N Barbier-Piraux, S Thorlacius, ...
Cancer research 52 (11), 3234-3236, 1992
|Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study|
EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ...
European urology 66 (3), 489-499, 2014
|TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains|
AL Børresen, TI Andersen, JE Eyfjörd, RS Cornelis, S Thorlacius, Å Borg, ...
Genes, Chromosomes and Cancer 14 (1), 71-75, 1995
|DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity|
BZ Yuan, X Zhou, ME Durkin, DB Zimonjic, K Gumundsdottir, JE Eyfjord, ...
Oncogene 22 (3), 445-450, 2003
|The topography of mutational processes in breast cancer genomes|
S Morganella, LB Alexandrov, D Glodzik, X Zou, H Davies, J Staaf, ...
Nature communications 7 (1), 1-11, 2016